Ticker Launch
Sign inTry it free

SPAC · Merger completed

Tottenham Acquisition I Ltd

Business combination with Clene Nanomedicine, Inc.

Tottenham Acquisition I Ltd is a blank-check company (SPAC) that raised $40M in its initial public offering on Aug 2, 2018, listing on Nasdaq Capital Market. It completed its business combination with Clene Nanomedicine, Inc. on Dec 30, 2020; the combined company is Clene Inc. (CLNN). Loeb & Loeb advised the SPAC and Hunter Taubman Fischer & Li advised the underwriters on the IPO.

Clene Nanomedicine is a clinical-stage biopharmaceutical company developing therapeutic candidates for neurodegenerative diseases. Founded in 2013, it is based in Salt Lake City, Utah, with research and manufacturing operations in North East, Maryland.

Status
Merger completed
IPO date
Aug 2, 2018
IPO size
$40M
IPO exchange
Nasdaq Capital Market
Target
Clene Nanomedicine, Inc.
Announced
Sep 2, 2020
Closed
Dec 30, 2020
Combined company
Clene Inc. (CLNN)
SPAC counsel (IPO)
Loeb & Loeb and Collas Crill
Underwriters' counsel (IPO)
Hunter Taubman Fischer & Li

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2020